Experts from NASA are keeping a close eye on UK ... the GLP-1 used in AZ's diabetes drug Bydureon. NASA’s chief health and medical officer Dr James Polk said: “Although our mechanism for ...

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

GLP1RA mimics the GLP-1 hormone in the body that helps control ... Strawbridge, Ph.D., of the University of Glasgow, in the UK. More information: Madeleine M. E. Hayman et al, Association of ...

or it had a different mechanism of action. “There’s a lot of hype and excitement around GLP-1 and like medications,” Youssef. “And the thing I want to see is long-term safety data.

Over a median of 3.68 years, adults with type 2 diabetes who added a GLP-1 agent to their treatment ... were likely driven by two main mechanisms of action -- the first being a reduction in ...

prompting companies to not only develop drugs with a similar mechanism of action (MOA), but also to explore and investigate novel targets. While Wegovy was not the first GLP-1 receptor agonist ...